1. Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer
   Simona Bramante et al, 2016, OncoImmunology CrossRef
2. Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches
   Nasser Hashemi Goradel et al, 2019, Journal of Cellular Physiology CrossRef
3. Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer
   Q Yang et al, 2014, British Journal of Cancer CrossRef
4. Tumor Dynamics in Response to Antiangiogenic Therapy with Oral Metronomic Topotecan and Pazopanib in Neuroblastoma Xenografts
   Sushil Kumar et al, 2013, Translational Oncology CrossRef
5. Synergistic Antitumor Effects of Doxorubicin‐Loaded Carboxymethyl Cellulose Nanoparticle in Combination with Endostar for Effective Treatment of Non‐Small‐Cell Lung Cancer
   Mingqiang Li et al, 2014, Advanced Healthcare Materials CrossRef
6. Exploring the molecular role of endostatin in diabetic neuropathy
   Tuhin Mukherjee et al, 2021, Molecular Biology Reports CrossRef
7. Effect of Grape Procyanidins on Tumor Angiogenesis in Liver Cancer Xenograft Models
   Li-Li Feng et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
8. Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant
   Maolei Xu et al, 2013, Tumor Biology CrossRef
9. Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM‐CSF: Results in vitro, in rodents and in humans
   Simona Bramante et al, 2015, International Journal of Cancer CrossRef
10. Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models
    Leandro E. Mainetti et al, 2020, Oncotarget CrossRef
11. Effectiveness of treatment with endostatin in combination with emcitabine, carboplatin, and gemcitabine in patients with advanced non-small cell lung cancer: a retrospective study
    Xun Yu et al, 2018, Open Medicine CrossRef
12. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
    Lan Deng et al, 2023, Open Life Sciences CrossRef